Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-alpha therapy in a patient with psoriatic arthritis and psoriasis vulgaris.
Antoniou
C
C
Dessinioti
C
C
Katsambas
A
A
Stratigos
A J
AJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000097:blood / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced*; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol; D000069285:Infliximab